Psychedelics as a novel approach to treating autoimmune conditions
Immunology Letters October 6, 2020 Caitlin Thompson, Attila Szabo 69 citations
With a rise in the incidence of autoimmune diseases (AiD), health care providers continue to seek out more efficacious treatment approaches for the AiD patient population. Classic serotonergic psychedelics have recently been gaining public and professional interest as novel interventions to a number of mental health afflictions. Psychedelics have also been shown to be able to modulate immune...